Migrainous infarction: a rare and often overlooked diagnosis
Gabriel Afonso Dutra Kreling; Neuro Rodrigues de Almeida Neto; Pedro José dos Santos Neto
Abstract
Migraine is a neurological entity and a well-known independent risk factor for cerebral infarction, which mostly afflicts the young female population. Researching focal neurological signs in this subset of the population with the diagnosis of a neurological ischemic event should always take into account the migraine as the etiology or as an associated factor. The etiology of central nervous system (CNS) ischemia is considerable. Migraine, although rare, also may be included in this vast etiological range, which is called migrainous infarction. In this setting, the diagnostic criteria required for this diagnosis is extensive. Herein, we present the case of a female adolescent who submitted to the emergency facility complaining of diplopia, dysarthria, and imbalance, which started concomitantly with a migrainous crisis with aura—a challenging clinical case that required extensive research to address all possible differential diagnoses.
Keywords
References
1. Haines DE. Neuroanatomy: an atlas of structures, sections, and systems. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2011.
2. Campbell WW. DeJong’s the neurologic examination. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2013.
3. Ropper AH, Samuels MA, Klein JP, editors. Adams and Victor’s principles of neurology. 10th ed. New York: McGraw-Hill Education; 2014.
4. Keane JR. Internuclear ophthalmoplegia: unusual causes in 114 of 410 patients. Arch Neurol. 2005;62(5):714-7. PMid:15883257. http://dx.doi.org/10.1001/archneur.62.5.714.
5. Kim JS. Internuclear ophthalmoplegia as an isolated or predominant symptom of brainstem infarction. Neurology. 2004;62(9):1491-6. PMid:15136670. http://dx.doi.org/10.1212/01.WNL.0000123093.37069.6D.
6. Zee DS, Hain TC, Carl JR. Abduction nystagmus in internuclear ophthalmoplegia. Ann Neurol. 1987;21(4):383-8. PMid:3579224. http://dx.doi.org/10.1002/ana.410210411.
7. Williams LS, Garg BP, Cohen M, Fleck JD, Biller J. Subtypes of ischemic stroke in children and young adults. Neurology. 1997;49(6):1541-5. PMid:9409343. http://dx.doi.org/10.1212/WNL.49.6.1541.
8. Carvalho KS, Garg BP. Arterial strokes in children. Neurol Clin. 2002;20(4):1079-100, vii. PMid:12616682. http://dx.doi.org/10.1016/S0733-8619(02)00012-9.
9. Mackay MT, Wiznitzer M, Benedict SL, Lee KJ, Deveber GA, Ganesan V. Arterial ischemic stroke risk factors: The international pediatric stroke study. Ann Neurol. 2011;69(1):130-40. PMid:21280083. http://dx.doi.org/10.1002/ana.22224.
10. Tsze DS, Valente JH. Pediatric stroke: a review. Emerg Med Int. 2011;2011:1-10. PMID: 22254140. http://dx.doi.org/10.1155/2011/734506.
11. Kirkham FJ. Stroke in childhood. Arch Dis Child. 1999;81(1):85-9. PMid:10373145. http://dx.doi.org/10.1136/adc.81.1.85.
12. Eeg-Olofsson O, Ringheim Y. Stroke in children: clinical characteristics and prognosis. Acta Paediatr Scand. 1983;72(3):391-5. PMid:6880725. http://dx.doi.org/10.1111/j.1651-2227.1983.tb09734.x.
13. Riela AR, Roach ES. Etiology of stroke in children. J Child Neurol. 1993;8(3):201-20. PMid:8409261. http://dx.doi.org/10.1177/088307389300800302.
14. Gold AP, Carter S. Acute hemiplegia of infancy and childhood. Pediatr Clin North Am. 1976;23(3):413-33. PMid:958742. http://dx.doi.org/10.1016/S0031-3955(16)33313-2.
15. Sem S, Oppenheimer S. Bedside assessment of stroke and stroke mimics. Ann Indian Acad Neurol. 2008;11(5):S4-11.
16. Pavlakis SG, Kingsley PB, Bialer MG. Stroke in children: genetic and metabolic issues. J Child Neurol. 2000;15(5):308-15. PMid:10830197. http://dx.doi.org/10.1177/088307380001500507.
17. Roach ES, Riela AR. Pediatric cerebrovascular disorders. 2nd ed. New York: Futura; 1995.
18. Kirkham FJ. Stroke in childhood. Arch Dis Child. 1999;81(1):85-9. PMid:10373145. http://dx.doi.org/10.1136/adc.81.1.85.
19. Dellavance A, Gabriel A Jr, Cintra AFU, et al. II Brazilian Consensus on Antinuclear Antibodies in Hep-2 Cells Definitions for standardization of autoantibody testing against the nucleus (ANA Hep-2), nucleolus, cytoplasm and mitotic apparatus, as well as its clinical associations. Rev Bras Reumatol. 2003;43(3):129-40. http://dx.doi.org/10.1590/S0482-50042003000300002.
20. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343-9. PMid:17261680. http://dx.doi.org/10.1212/01.wnl.0000252808.97649.21.
21. Burch RC, Loder S, Loder E, Smitherman TA. The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache. 2015;55(1):21-34. PMid:25600719. http://dx.doi.org/10.1111/head.12482.
22. Rambarat CA, Elgendy IY, Johnson BD, et al. Migraine headache and long-term cardiovascular outcomes: an extended follow-up of the Women’s Ischemia Syndrome Evaluation. Am J Med. 2017;130(6):738-43. PMid:28109970. http://dx.doi.org/10.1016/j.amjmed.2016.12.028.
23. Kurth T, Winter AC, Eliassen AH, et al. Migraine and risk of cardiovascular disease in women: prospective cohort study. BMJ. 2016;353:i2610. PMid:27247281. http://dx.doi.org/10.1136/bmj.i2610.
24. Spector JT, Kahn SR, Jones MR, Jayakumar M, Dalal D, Nazarian S. Migraine headache and ischemic stroke risk: an updated meta-analysis. Am J Med. 2010;123(7):612-24. PMid:20493462. http://dx.doi.org/10.1016/j.amjmed.2009.12.021.
25. Schürks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ. 2009;339(oct27 1):b3914. PMid:19861375. http://dx.doi.org/10.1136/bmj.b3914.
26. Abanoz Y, Gülen Abanoz Y, Gündüz A, et al. Migraine as a risk factor for young patients with ischemic stroke: a case-control study. Neurol Sci. 2017;38(4):611-7. PMid:28083761. http://dx.doi.org/10.1007/s10072-017-2810-3.
27. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808. PMid:23771276. http://dx.doi.org/10.1177/0333102413485658.
28. Stang PE, Carson AP, Rose KM, et al. Headache, cerebrovascular symptoms, and stroke: the atherosclerosis risk in communities study. Neurology. 2005;64(9):1573-7. PMid:15883318. http://dx.doi.org/10.1212/01.WNL.0000158326.31368.04.
29. Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ. 2005;330(7482):63. PMid:15596418. http://dx.doi.org/10.1136/bmj.38302.504063.8F.
30. Lee MJ, Lee C, Chung C-S. The migraine–stroke connection. JoS. 2016;18(2):146-56. http://dx.doi.org/10.5853/jos.2015.01683. PMid:27283278.
31. Spalice A, Del Balzo F, Papetti L, et al. Stroke and migraine is there a possible comorbidity? Ital J Pediatr. 2016;42(1):41. PMid:27113086. http://dx.doi.org/10.1186/s13052-016-0253-8.
32. Sacco S, Ornello R, Ripa P, Pistoia F, Carolei A. Migraine and hemorrhagic stroke: a meta-analysis. Stroke. 2013;44(11):3032-8. PMid:24085027. http://dx.doi.org/10.1161/STROKEAHA.113.002465.
33. Sochurkova D, Moreau T, Lemesle M, Menassa M, Giroud M, Dumas R. Migraine history and migraine-induced stroke in the Dijon stroke registry. Neuroepidemiology. 1999;18(2):85-91. PMid:10023131. http://dx.doi.org/10.1159/000069411.
34. Arboix A, Massons J, Garcia-Eroles L, Oliveres M, Balcells M, Targa C. Migrainous cerebral infarction in the Sagrat Cor Hospital of Barcelona stroke registry. Cephalalgia. 2003;23(5):389-94. PMid:12780770. http://dx.doi.org/10.1046/j.1468-2982.2003.00534.x.
35. Wolf ME, Szabo K, Griebe M, et al. Clinical and MRI characteristics of acute migrainous infarction. Neurology. 2011;76(22):1911-7. PMid:21624990. http://dx.doi.org/10.1212/WNL.0b013e31821d74d5.
36. Laurell K, Artto V, Bendtsen L, et al. Migrainous infarction: a Nordic multicenter study. Eur J Neurol. 2011;18(10):1220-6. PMid:21414105. http://dx.doi.org/10.1111/j.1468-1331.2011.03364.x.
37. Guo S, Olesen J, Ashina M. Phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cyclic AMP increase. Brain. 2014;137(Pt 11):2951-9. PMid:25161294. http://dx.doi.org/10.1093/brain/awu244.
38. Kruuse C, Lassen LH, Iversen HK, Oestergaard S, Olesen J. Dipyridamole may induce migraine in patients with migraine without aura. Cephalalgia. 2006;26(8):925-33. PMid:16886928. http://dx.doi.org/10.1111/j.1468-2982.2006.01137.x.
39. Evers S, Afra J, Frese A, et al. EFNS guideline on the drug treatment of migraine: revised report of an EFNS task force. Eur J Neurol. 2009;16(9):968-81. PMid:19708964. http://dx.doi.org/10.1111/j.1468-1331.2009.02748.x.
40. Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78(17):1337-45. PMid:22529202. http://dx.doi.org/10.1212/WNL.0b013e3182535d20.
41. Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA. 2003;289(1):65-9. PMid:12503978. http://dx.doi.org/10.1001/jama.289.1.65.
42. Schrader H, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ. 2001;322(7277):19-22. PMid:11141144. http://dx.doi.org/10.1136/bmj.322.7277.19.
43. Liberopoulos EN, Mikhailidis DP. Could statins be useful in the treatment of patients with migraine? Headache. 2006;46(4):672-5. PMid:16643563. http://dx.doi.org/10.1111/j.1526-4610.2006.00293.x.
Publication date:
06/29/2017
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email